Studiedocumentatie
| Open studies |
| Trial | RISOTTO | ||||
| Middelen | Ravulizumab | ||||
| Lijn | Leeftijd | Fase | Location | Status | |
|---|---|---|---|---|---|
| 3e lijns | ≥ 18 jaar | Fase 4 | Amsterdam UMC | Open | |
| Open studies |
| Trial | RISOTTO | ||||
| Middelen | Ravulizumab | ||||
| Lijn | Leeftijd | Fase | Location | Status | |
|---|---|---|---|---|---|
| 3e lijns | ≥ 18 jaar | Fase 4 | Amsterdam UMC | Open | |